Combination therapy for HCC: from CRISPR screening to the design of clinical therapies.
Signal transduction and targeted therapy, 6(1): 359 PMID 34608130 DOI 10.1038/s41392-021-00775-1
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.